Aussie radiopharma company Advancell Co. Ltd. unveiled promising early clinical data that could redefine how advanced ...

Biopharma financings from January through October 2025 totaled $61.45 billion, roughly in line with the $61.04 billion raised ...

Antibody-drug conjugates (ADCs) carrying topoisomerase I (TOP1) inhibitors, such as trastuzumab deruxtecan (T-DXd), have ...

Phase II data being presented at the American Association for the Study of Liver Diseases annual meeting indicate drug ...

Enara Bio Ltd. is staking a claim to having validated the first in a new class of tumor antigens derived from unannotated ...

UNESCO has adopted the first set of global standards on the ethics of neurotechnology amid the rapid advancement in the ...

San Francisco Bay Area researchers from UC Berkeley, UC San Francisco and Stanford University have combined their ...

Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the ...

Neok Bio Inc. was formed earlier this year and is already on schedule to file an IND in a few months for its two bispecific ...

Researchers at Crossbridge Bio Inc. have conducted preclinical evaluation of CBB-120, a novel TROP2-directed dual-payload ADC ...

Billiontoone Inc. saw its shares surge well beyond the already upsized $60 IPO price, opening at $100 each, giving the ...

Zhongshan Innovation New Drug Development Co. Ltd. has described conjugates comprising a chelating ligand moiety, a fibroblast activation protein α (FAP) ligand and integrin αvβ3 or integrin αvβ6 ...